The nuclear Ferredoxin reductase and its role in tumor suppression

NIH RePORTER · NIH · R01 · $479,293 · view on reporter.nih.gov ↗

Abstract

Project Summary/Abstract We and others showed that ferredoxin reductase (FDXR), a mitochondrial flavoprotein, is induced by DNA damage in a p53-dependent manner and regulates apoptosis induced by reactive oxygen species. As the only human ferredoxin reductase, FDXR receives two electrons from NADPH and transfers them one at a time to its cognate substrates ferredoxin 1 (FDX1) and FDX2 and subsequently, plays a role in biogenesis of steroids and iron sulfur cluster proteins. Despite these well-defined biochemical functions, the role of FDXR in tumor suppression is still poorly understood. Interestingly, recent studies showed that FDXR is the most consistent acute sensor following DNA damage, suggesting that FDXR plays a role in DNA damage response and repair. Indeed, our pilot studies showed that FDXR is also expressed in the nucleus and regulates cell growth and survival potentially via its nuclear substrates (p53, Mdm2, and Mdm4) in response to a stress. These observations prompt us to hypothesize that the nuclear FDXR has a critical biological function in tumor suppression. To further test this, two specific aims are proposed: (1) To determine how FDXR subcellular localization is regulated; (2) To determine how the nuclear FDXR exerts its biological function.

Key facts

NIH application ID
10882601
Project number
1R01CA283368-01A1
Recipient
UNIVERSITY OF CALIFORNIA AT DAVIS
Principal Investigator
Xinbin Chen
Activity code
R01
Funding institute
NIH
Fiscal year
2024
Award amount
$479,293
Award type
1
Project period
2024-05-01 → 2029-04-30